VEGFA and retinopathy of prematurity: Recently, CARE-ROP study also showed that the plasma VEGF levels were not systematically altered after 0.12 mg or 0.2 mg ranibizumab injections per eye in the infants with bilateral ROP, and the lower-dose ranibizumab appeared to be as effective as the other [24].